Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Reflections From J.P. Morgan: Challenges As Always And Reasons For Optimism

Jan 12 2018

• By Jessica Merrill

San Francisco, CA

Related Content

Spark's Luxturna Approval Ushers In A New Gene Therapy Era

Dec 19 2017

Trump Throws Pharma A Curve Ball On The Third Day Of J.P. Morgan

Jan 12 2017

Celgene's $1.1bn Impact Buy Is First Of More Deals To Come In 2018 And Beyond

Jan 09 2018

Related Companies

Bristol Myers Squibb Company

Impact Biomedicines, Inc.

GSK plc

Novartis AG

Biogen, Inc.

Regeneron Pharmaceuticals, Inc.

Sanofi

Express Scripts Holding Company

Merck & Co., Inc.

Viatris Inc.

Spark Therapeutics, Inc.

Gilead Sciences, Inc.

Kite Pharma, Inc.

Constellation Pharmaceuticals, Inc.

Additional Topics

Pricing Debate Business Strategies Strategy Policy Commercial BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window